New

Vernus AI

The AI engine Fit Assessment

Beta

The company develops AI and quantum computing solutions to optimize pharmaceutical manufacturing and support drug development.

Blurb

Vernus AI develops AI and quantum computing tools to optimize pharmaceutical manufacturing processes and support drug development.

HQ Location

Taipei (Taiwan)

Founded

2025

Employees

11 - 50

Total funding raised

Not available

Funding Status

Not available

Vernus AI is a global leader in Pharmaceutical AI and Quantum Computing, dedicated to revolutionizing the world of drug manufacturing.



Through our revolutionary ReAIX platform, we bridge the gap between cutting-edge technology and deep scientific expertise. By training top-tier Large Language Models (LLMs) with specialized domain knowledge, we have built a suite of expert AI Agents specialized in Chemistry, Biology, and Pharmaceutics.



Our Innovation Strategy

We leverage Quantum Digital Annealing and multi-scale simulations to generate robust synthetic data. This allows us to create high-fidelity Digital Twins that:

•Optimize complex manufacturing processes

•Significantly increase production yields

•Solve the industry’s most intricate scale-up challenges



A Global Partner in Drug Development

Vernus AI is more than just a software provider. We are a dual-model international AI powerhouse:

•AI Software Services: Providing the tools to unlock new levels of industrial productivity.

•Pipeline Development: Collaborating on joint drug development projects with world-class and domestic pharmaceutical leaders.



At Vernus AI, we are committed to unlocking the next generation of productivity for the global pharmaceutical industry.